by Rachel LaBreck | Sep 24, 2025 | News
Lakeway, TX – Vigilant Biosciences is pleased to announce the successful approval of its BeVigilant™ OraFusion™ System under the In Vitro Diagnostic Regulation (IVDR), marking a significant milestone for international expansion. Additionally, Vigilant received...
by Rachel LaBreck | Sep 22, 2025 | News
Lakeway, TX – Vigilant Biosciences, a leader in the development of innovative solutions for the early detection of oral cancer, is pleased to announce that the U.S. Food and Drug Administration (FDA) has aligned on clinical requirements for a pivotal multi-site trial...
by Rachel LaBreck | Mar 8, 2025 | News
The BeVigilant™ OraFusion™ System was recently recognized by Inside Dentistry as one of the “10 Dental Technologies That Inspire for 2025.” The article spotlights our innovative, saliva-based test that enables early detection of oral cancer biomarkers right from the...
by Rachel LaBreck | Dec 20, 2024 | News
Breaking Cancer News dives into how Vigilant Biosciences® is advancing the early detection of oral cancer with its BeVigilant™ OraFusion™ System. The article features insights from oral surgeon Dr. William Shepard, who shares how this biomarker-driven saliva test is...
by Rachel LaBreck | Jun 25, 2024 | News
Dental Economics recently featured Vigilant Biosciences® and our BeVigilant™ OraFusion™ System in an article highlighting advancements in early oral cancer detection. The OraFusion System is a real-time, saliva-based test that enables dental professionals to identify...
by Rachel LaBreck | Jun 10, 2024 | News
We’re thrilled to see the BeVigilant™ OraFusion™ System featured in DSOPro as a key innovation shaping the future of DSOs. The article highlights how the BeVigilant™ OraFusion™ System enables clinicians to detect early signs of oral cancer in real-time, right from the...
EN 
IT 
DE 
TR 
PT 
NL 
FR 
ES